NAUTIKA1: A multicenter phase II study with a PD-L1+ cohort of patients receiving atezolizumab (atezo) with low-dose stereotactic body radiation therapy (SBRT) as neoadjuvant therapy for resectable stage IB-III NSCLC Meeting Abstract
| Authors: | Tian, S.; Kozono, D. E.; Ohri, N.; Jolly, S.; Johnson, B. E.; Chaft, J.; Toloza, E. M.; Ding, B.; Ngiam, C.; Schulz, K.; Bara, I.; Lee, J. M. |
| Abstract Title: | NAUTIKA1: A multicenter phase II study with a PD-L1+ cohort of patients receiving atezolizumab (atezo) with low-dose stereotactic body radiation therapy (SBRT) as neoadjuvant therapy for resectable stage IB-III NSCLC |
| Meeting Title: | 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2022) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 114 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Oct 23-26 |
| Meeting Location: | Virtual |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-11-01 |
| Start Page: | e392 |
| End Page: | e393 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2022.07.1550 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstracts: 2877 -- In section "Poster Q & A Sessions"-- Source: Cinahl |
